公开(公告)号：US20180116982A1

公开(公告)日：2018-05-03

申请号：US15575655

申请日：2016-05-17

Applicant: THERAPIX BIOSCIENCES LTD.

Inventor： Ascher SHMULEWITZ ,  Elran HABER ,  Ephraim BRENER

IPC: A61K31/164 ,  A61K31/485 ,  A61P25/04

CPC classification number: A61K31/164 ,  A61K31/485 ,  A61P25/04 ,  A61K2300/00

Abstract: The present invention provides pharmaceutical compositions comprising opioids and N-acylethanolamines, and methods for their use in preventing and treating a variety of opioid-responsive conditions and opioid-related side-effects.

公开(公告)号：US20180078523A1

公开(公告)日：2018-03-22

申请号：US15570118

申请日：2016-04-19

Applicant: THERAPIX BIOSCIENCES LTD.

Inventor： Ascher SHMULEWITZ ,  Elran HABER ,  Ephraim BRENER

IPC: A61K31/352 ,  A61K31/164 ,  A61K36/185

CPC classification number: A61K31/352 ,  A61K31/164 ,  A61K36/185 ,  A61K45/06 ,  A61P25/00 ,  A61P25/14 ,  A61P25/30 ,  A61P29/00 ,  A61K2300/00

Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.